<DOC>
	<DOC>NCT02575833</DOC>
	<brief_summary>A phase 2a, multicenter, randomized, double-blind, placebo-controlled study in subjects with stable angina to evaluate the effect of AMG 334 compared to placebo on exercise time during an exercise treadmill test (ETT)</brief_summary>
	<brief_title>Treadmill CV Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina, Stable</mesh_term>
	<criteria>History of chronic stable angina or at least 3 months prior to screening, with at least 1 angina episode per month Ischemic Heart disease documented by Myocardial Infarction, Coronary angiography or a Revascularization procedure Receiving stable doses of cardiac medication Completes 2 ETTs during screening meeting protocol requirements Participating in another investigational study Current or prior malignancy within 5 years of randomization Known sensitivity to any components of the investigational product Not able to complete all protocol required study visits Having the following within 3 months prior to or during screening: Unstable angina or acute coronary syndrome, Transient Ischemic attack(TIA) or stroke, Revasculatization procedure, or Instability in STsegment depression between screening ETTs, as assessed by the core ECG Laboratory</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Angina</keyword>
	<keyword>Stable Angina</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Exercise-induced Angina</keyword>
</DOC>